Use of chemotherapy at the end of life among Taiwanese cancer decedents, 2001–2006

References

• Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004;22:315–21.
   PubMed Web of Science ®Google Scholar
• Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: Is it a quality-of-care issue? J Clin Oncol 2008;26:3860–6.
   PubMed Web of Science ®Google Scholar
• Setoguchi S, Earle CC, Glynn R, Stedman M, Polinski JM, Corcoran CP, . Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol 2008;26:5671–8.
   PubMed Web of Science ®Google Scholar
• Sharma G, Freeman J, Zhang D, Goodwin JS. Trends in end-of-life ICU use among older adults with advanced lung cancer. Chest 2008;133:72–8.
   PubMed Web of Science ®Google Scholar
• Keam B, Oh DY, Lee SH, Kim DW, Kim MR, Im SA, . Aggressiveness of cancer-care near the end-of-life in Korea. Jpn J Clin Oncol 2008;38:381–6.
   PubMed Web of Science ®Google Scholar
• Goncalves JF, Goyanes C. Use of chemotherapy at the end of life in a Portuguese oncology center. Support Care Cancer 2008;16:321–7.
   PubMed Web of Science ®Google Scholar
• Temel JS, McCannon J, Greer JA, Jackson VA, Ostler P, Pirl WF, . Aggressiveness of care in a prospective cohort of patients with advanced NSCLC. Cancer 2008;113:826–33.
   PubMed Web of Science ®Google Scholar
• Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 2003;21:1133–8.
   PubMed Web of Science ®Google Scholar
• Keating NL, Ladrum MB, Lamont EB, Earle CC, Bozeman SR, McNeil BJ. End-of-life care for older cancer patients in the veterans health administration versus the private sector. Cancer 2010;116:3732–9.
   PubMedGoogle Scholar
• Barbera L, Paszat L, Qiu F. End-of-life care in lung cancer patients in Ontario: Aggressiveness of care in the population and a description of hospital admissions. J Pain Symptom Manage 2008;35:267–74.
   PubMedGoogle Scholar
• Braga S, Miranda A, Fonseca R, Passos-Coelho JL, Fernandes A, Costa JD, . The aggressiveness of cancer care in the last three months of life: A retrospective single centre analysis. Psycho-Oncol 2007;16:863–8.
   PubMed Web of Science ®Google Scholar
• Martoni AA, Tanneberger S, Mutri V. Cancer chemotherapy near the end of life: The time has come to set guidelines for its appropriate use. Tumori 2007;93:417–22.
   PubMed Web of Science ®Google Scholar
• Kao S, Shafiq J, Vardy J, Adams D. Use of chemotherapy at end of life in oncology patients. Ann Oncol 2009;20:1555–9.
   PubMed Web of Science ®Google Scholar
• Barbera L, Paszat L, Chartier C. Indicators of poor quality end-of-life cancer care in Ontario. J Palliat Care 2006;22:12–7.
   PubMed Web of Science ®Google Scholar
• Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS. Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 2003;138:639–44.
   PubMed Web of Science ®Google Scholar
• Bureau of National Health Insurance. NHI profile. Available from: http://www.nhi.gov.tw/webdata/AttachFiles/Attach_12365_2_96承保-ch.pdf. (in Chinese) October 13, 2011.
   Google Scholar
• Bureau of Health Promotion. Cancer registry annual report, 2006 Taiwan. Available from: http://crs.cph.ntu.edu.tw/uploadimages/Y95-ALL.pdf. (in Chinese) October 13, 2011.
   Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Clin Epidemiol 1992;45:613–9.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373–83.
   PubMedGoogle Scholar
• Burton P, Gurrin L, Sly P. Extending the simple linear regression model to account for correlated responses: An introduction to generalized estimating equations and multi-level mixed modeling. Stat Med 1998;17:1261–91.
   PubMed Web of Science ®Google Scholar
• Grunfeld E, Lethbridge L, Dewar R, Lawson B, Paszat LF, Johnston G, . Towards using administrative databases to measure population-based indicators of quality end-of-life care: Testing the methodology. Palliat Med 2006;20:769–77.
   PubMed Web of Science ®Google Scholar
• Sato K, Miyashita M, Morita T, Sanjo M, Shima Y, Uchitomi Y. Quality of end-of-life treatment for cancer patients in general wards and the palliative care unit at a regional cancer center in Japan: A retrospective chart review. Support Care Cancer 2008;16:113–22.
   PubMed Web of Science ®Google Scholar
• Yun YH, Kwak M, Park SM, Kim S, Choi JS, Lim HY, . Chemotherapy use and associated factors among cancer patients near the end of life. Oncology 2007;72:164–71.
   PubMed Web of Science ®Google Scholar
• Asola R, Huhtala H, Holli K. Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer. Breast Cancer Res Treat 2006;100: 77–82.
   PubMed Web of Science ®Google Scholar
• Bookwala J, Coppola KM, Fagerlin A, Ditto PH, Danks JH, Smucker WD. Gender differences in older adults’ preferences for life-sustaining medical treatments and end-of-life values. Death Studies 2001;25:127–49.
   PubMed Web of Science ®Google Scholar
• Carr D, Khodyakov D. End-of-life health care planning among young-old adults: An assessment of psychosocial influences. J Gerontol: Soc Sci 2007;62B:S135–41.
   Google Scholar
• Shugarman LR, Decker SL, Bercovitz A. Demographic and social characteristics and spending at the end of life. J Pain Symptom Manage 2009;38:15–26.
   PubMedGoogle Scholar
• Iwashyna TJ, Christakis NA. Marriage, widowhood, and health-care use. Soc Sci Med 2003;57:2137–47.
   PubMed Web of Science ®Google Scholar
• Jatoi A, Novotny P, Cassivi S, Clark MM, Midthun D, Patten CA, . Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the Mayo Clinic Lung Cancer Cohort. Oncologist 2007;12:1456–63.
   PubMed Web of Science ®Google Scholar
• Wachterman MW, Sommers BD. The impact of gender and marital status on end-of-life care: Evidence from the National Mortality Follow-Back Survey. J Palliat Med 2006;9:343–52.
   PubMed Web of Science ®Google Scholar
• Jennens RR, Boer RD, Irving L, Ball DL, Rosenthal MA. Differences of opinion: A survey of knowledge and bias among clinicians regarding the role of chemotherapy in metastatic non-small cell lung cancer. Chest 2004;126:1985–93.
   PubMedGoogle Scholar
• Matsuyama R, Reddy S, Smith TJ. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 2008;24:3490–6.
   Google Scholar
• Grunfeld E, Urquhart R, Mykhalovskiy E, Folkes A, Johnston G, Burge FI, . Toward population-based indicators of quality end-of-life care: Testing stakeholder agreement. Cancer 2008;112:2301–8.
   PubMed Web of Science ®Google Scholar
• Tang ST, Liu TW, Lai MS, Liu LN, Chen CH. Concordance of preferences for end-of-life care between terminally-ill cancer patients and their family caregivers in Taiwan. J Pain Symptom Manage 2005;30:510–8.
   PubMedGoogle Scholar
• Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, . Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 1998;279:1709–14.
   PubMed Web of Science ®Google Scholar